Position: Site Leader
Position: Global Community Advisory Board Representative
Position: Principal Investigator, Johns Hopkins Professor of Medicine and Public Health; Deputy Director, CCGHE
Position: CRS Site Director
Position: CRS Leader and Director
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
This study will include people who have very recently been infected with HIV and will start anti-HIV (antiretroviral) drugs...
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...
The study is being done to:
test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...